Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coxibs: Evolving role in pain management.

Nathaniel Katz1

  • 1Department of Anesthesia, Harvard Medical School, Boston, MA, USA.

Seminars in Arthritis and Rheumatism
|January 16, 2003
PubMed
Summary

Cyclooxygenase (COX)-2 specific inhibitors (coxibs) offer effective pain relief for chronic and acute conditions. They provide a superior safety profile compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs), with fewer gastrointestinal complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of LEVI-04 in patients with osteoarthritis of the knee: a randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet (London, England)·2026
Same author

Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trial.

Osteoarthritis and cartilage·2024
Same author

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain.

Pain·2024
Same author

What can be done to control the placebo response in clinical trials? A narrative review.

Contemporary clinical trials·2021
Same author

Design and conduct of confirmatory chronic pain clinical trials.

Pain reports·2021
Same author

Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations.

Pain·2021

Area of Science:

  • Pain Management
  • Pharmacology
  • Inflammation

Background:

  • Traditional analgesics like NSAIDs and acetaminophen have limitations in efficacy and safety.
  • Opioids carry risks of addiction and side effects.
  • Novel therapeutic targets are needed for effective pain management.

Purpose of the Study:

  • To evaluate the efficacy and safety of Cyclooxygenase (COX)-2 specific inhibitors (coxibs) in pain management.
  • To compare coxibs with traditional NSAIDs regarding gastrointestinal (GI) complications and antiplatelet effects.
  • To explore the potential role of coxibs in comprehensive pain management strategies.

Main Methods:

  • Review of clinical trials and studies on coxibs for various pain conditions.
  • Comparative analysis of coxibs versus non-selective NSAIDs.
  • Assessment of safety profiles, focusing on GI and antiplatelet effects.

Main Results:

  • Coxibs demonstrate comparable efficacy to traditional NSAIDs in treating chronic arthritic pain.
  • Coxibs are effective for acute pain management in settings like orthopedic and dental surgery, and dysmenorrhea.
  • Coxibs exhibit a superior safety profile with reduced GI complications and antiplatelet effects compared to NSAIDs.

Conclusions:

  • Coxibs represent a viable therapeutic option for chronic and acute pain.
  • The favorable safety profile of coxibs supports their integration into balanced analgesic regimens.
  • Coxibs hold potential for inclusion in pain management algorithms, including for cancer pain.

Related Experiment Videos